Apnimed (APMD) Director William A. Jones Jr Receives Award

What Happened

• William A. Jones Jr, a director of Apnimed, received a grant of derivative securities equal to 44,477 shares on July 30, 2026 (grant reported as $0.00 per share, non‑cash award). The filing also shows a related disposition to the issuer and a re‑grant of the same 44,477 derivative shares on August 3, 2026, consistent with a reclassification described in the filing. No cash changed hands in these transactions.

Key Details

• Transaction dates and prices:
  • 2026-07-30: Grant (A) of 44,477 derivative shares at $0.00 (value $0).
  • 2026-08-03: Disposition to issuer (D) of 44,477 derivative shares at $0.00 (value $0).
  • 2026-08-03: Grant (A) of 44,477 derivative shares at $0.00 (value $0).
• Shares owned after transaction: not specified in the provided filing details.
• Footnote F1: The activity reflects a reclassification (each Class A share reclassified into one share of Common Stock) exempt under Rule 16b‑7 and Rule 16b‑3.
• Footnote F2: The derivative award vests in substantially equal monthly installments over 36 months beginning July 30, 2026, contingent on the reporting person’s continued service.
• Filing timeliness: The Form 4 was filed on Aug 3, 2026 for transactions dated July 30, 2026 (filed within the standard 2 business‑day reporting window).

Context

• These transactions are derivative awards (options/awarded rights), not open‑market purchases or sales; the zero dollar amounts indicate a compensation grant or reclassification rather than a market trade. Such grants are common for director compensation and will only convert into actionable equity as they vest and are exercised or otherwise settled in the future.